<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:08:22Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/14555" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/14555</identifier><datestamp>2026-10-18T21:14:23Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Prevention of infertility induced by ovarian ischemia reperfusion injury by benidipine in rats: Biochemical, gene expression, histopathological and immunohistochemical evaluation</dc:title><dc:creator>Unlubilgin, E.</dc:creator><dc:creator>Suleyman, B.</dc:creator><dc:creator>Balci, G.</dc:creator><dc:creator>Atakan Al, R.</dc:creator><dc:creator>Cankaya, M.</dc:creator><dc:creator>Arslan Nayki, U.</dc:creator><dc:creator>Suleyman, H.</dc:creator><dc:subject>Benidipine</dc:subject><dc:subject>Ischemia</dc:subject><dc:subject>Ovary</dc:subject><dc:subject>Rat</dc:subject><dc:subject>Reperfusion</dc:subject><dc:subject>Animals</dc:subject><dc:subject>Apoptosis</dc:subject><dc:subject>Dihydropyridines</dc:subject><dc:subject>Female</dc:subject><dc:subject>Gene Expression</dc:subject><dc:subject>Glutathione</dc:subject><dc:subject>Infertility, Female</dc:subject><dc:subject>Interleukin-1beta</dc:subject><dc:subject>Malondialdehyde</dc:subject><dc:subject>Models, Animal</dc:subject><dc:subject>Rats, Wistar</dc:subject><dc:subject>Reperfusion Injury</dc:subject><dc:subject>Tumor Necrosis Factor-alpha</dc:subject><dc:subject>Vasodilator Agents</dc:subject><dc:subject>caspase 3</dc:subject><dc:subject>interleukin 1beta</dc:subject><dc:subject>malonaldehyde</dc:subject><dc:subject>tumor necrosis factor</dc:subject><dc:subject>dihydropyridine derivative</dc:subject><dc:subject>vasodilator agent</dc:subject><dc:subject>animal experiment</dc:subject><dc:subject>animal model</dc:subject><dc:subject>animal tissue</dc:subject><dc:subject>Article</dc:subject><dc:subject>cell death</dc:subject><dc:description>Introduction Benidipine has been reported to prevent the ischemia/reperfusion (I/R) damage in heart tissue and to suppress oxidant and proinflammatory cytokine production, increased by I/R. However, There was no information about the effects of benidipine on I/R injury in the ovary and the damage of I/R-induced infertility. Objectives The aim of the study was to investigate the effects of benidipine on bilateral ovarian I/R injury and whether or not effective in the treatment of I/R-induced infertility in rats. Method Forty-eight females, albino Wistar rats were randomly divided into 4 groups: IRC group (ovarian I/R group, n = 12), IRB-2 group (ovarian I/R + 2 mg/kg benidipine group, n = 12), IRB-4 group (ovarian I/R + 4 mg/kg benidipine group, n = 12) and HG group (healthy group with sham operation, n = 12). In IRB-2 and IRB-4 groups, two hours ischemia and two hours reperfusion was performed following orally benidipine administration. After this I/R procedure, 6 rats from each group performed bilateral overectomy. Ovarian levels of malondialdehyde (MDA) and total glutathione (tGSH), ovarian gene expressions of interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) and also apoptosis were evaluated. The other 6 rats from each group were put in together with six male rats in separated cages for 2 months in order to reproduce. During this period, rats which did not become pregnant were accepted as infertile. Results MDA levels, expressions of TNF-α and IL-1β in IRC group were significantly higher than in the SGA group and tGSH was decreased. In total, 4 mg/kg benidipine has better prevented ovaries from the increase of oxidants and proinflammatory cytokines, the decrease of antioxidants than 2 mg/kg benedipine. In the histopathological examination hemorrhage, congestion, follicle degeneration, neutrophil infiltration and necrosis were seen in ovarian tissue of IRC group. Only dilated and congested blood vessels were found in the IRB-2 group. No histopathological finding was encountered in the IRB-4 group. I/R caused infertility in rats. In total, 4 mg/kg benidipine prevented from infertility better than the dose of 2 mg/kg benedipine. Conclusion In total, 4 mg/kg benidipine reduced I/R injury and I/R-related infertility more significantly compared to 2 mg/kg benedipine in rat ovaries. © 2017 Elsevier Masson SAS</dc:description><dc:publisher>Elsevier Masson SAS</dc:publisher><dc:date>2017</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/14555</dc:identifier><dc:identifier>https://doi.org/10.1016/j.jogoh.2016.12.001</dc:identifier><dc:identifier>2468-7847</dc:identifier><dc:language>en</dc:language><dc:relation>Journal of Gynecology Obstetrics and Human Reproduction</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/14555</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>